49 related articles for article (PubMed ID: 19585482)
41. Khat Chewing and Lipid Profile in Human and Experimental Animals.
Al-Duais MA; Al-Awthan YS
Biomed Res Int; 2021; 2021():6001885. PubMed ID: 34977243
[TBL] [Abstract][Full Text] [Related]
42. Khat use and related addiction, mental health and physical disorders: the need to address a growing risk.
Odenwald M; al'Absi M
East Mediterr Health J; 2017 May; 23(3):236-244. PubMed ID: 28493272
[TBL] [Abstract][Full Text] [Related]
43. Khat use and mental illness: a critical review.
Warfa N; Klein A; Bhui K; Leavey G; Craig T; Alfred Stansfeld S
Soc Sci Med; 2007 Jul; 65(2):309-18. PubMed ID: 17544193
[TBL] [Abstract][Full Text] [Related]
44. The neuropsychopharmacological effects of Catha edulis in mice offspring born to mothers exposed during pregnancy and lactation.
Bedada W; Engidawork E
Phytother Res; 2010 Feb; 24(2):268-76. PubMed ID: 19585482
[TBL] [Abstract][Full Text] [Related]
45. Khat (Catha edulis): health aspects of khat chewing.
Hassan NA; Gunaid AA; Murray-Lyon IM
East Mediterr Health J; 2007; 13(3):706-18. PubMed ID: 17687845
[TBL] [Abstract][Full Text] [Related]
46. The potential adverse effects of habitual use of Catha edulis (khat).
Al-Habori M
Expert Opin Drug Saf; 2005 Nov; 4(6):1145-54. PubMed ID: 16255671
[TBL] [Abstract][Full Text] [Related]
47. [Khat--a new drug of abuse in Norway].
Al-Samarraie M; Khiabani HZ; Opdal MS
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):574-6. PubMed ID: 17332809
[TBL] [Abstract][Full Text] [Related]
48. Khat: pharmacological and medical aspects and its social use in Yemen.
Al-Motarreb A; Baker K; Broadley KJ
Phytother Res; 2002 Aug; 16(5):403-13. PubMed ID: 12203257
[TBL] [Abstract][Full Text] [Related]
49. Khat chewing, cardiovascular diseases and other internal medical problems: the current situation and directions for future research.
Al-Motarreb A; Al-Habori M; Broadley KJ
J Ethnopharmacol; 2010 Dec; 132(3):540-8. PubMed ID: 20621179
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
